...
首页> 外文期刊>Circulation: An Official Journal of the American Heart Association >Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom prospective diabetes study (UKPDS) 79
【24h】

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom prospective diabetes study (UKPDS) 79

机译:静默性心肌梗死在新诊断的2型糖尿病中的预后意义:英国前瞻性糖尿病研究(UKPDS)79

获取原文
获取原文并翻译 | 示例
           

摘要

Background-: We aimed to determine the prevalence of silent myocardial infarction (SMI) in people with newly diagnosed type 2 diabetes mellitus and its relationships to future myocardial infarction (MI) and all-cause mortality. Methods and Results-: We examined data from the 5102 patients in the 30-year UK Prospective Diabetes Study (UKPDS) and used Cox proportional hazards regression to examine outcomes by SMI status. Of 1967 patients with complete baseline data, 326 (16.6%) had ECG evidence of SMI (Minnesota codes 1.1 or 1.2) at enrollment. Those with SMI were more likely to be older, female, sedentary, and nonsmokers compared with those without SMI. Their mean blood pressure was greater despite more intensive antihypertensive treatment; they were more likely to be taking aspirin and lipid-lowering therapy; and they had a greater prevalence of microangiopathy. Fully adjusted hazard ratios for those with versus those without SMI in multivariate models that included UKPDS Risk Engine variables were 1.58 (95% confidence interval, 1.22-2.05) for fatal MI and 1.31 (95% confidence interval, 1.10-1.56) for all-cause mortality. Hazard ratios for first fatal or nonfatal MI and for first nonfatal MI were nonsignificant. The net reclassification index showed no improvement when SMI was added to these models, and the integrated discrimination index showed that SMI marginally improved the prediction of fatal MI and all-cause mortality. Conclusions-: About 1 in 6 UKPDS patients with newly diagnosed type 2 diabetes mellitus had evidence of SMI, which was independently associated with an increased risk of fatal MI and all-cause mortality. However, identification of SMI does not add substantively to current UKPDS Risk Engine predictive variables. Clinical Trial Registration-: URL: http://www.controlled-trials.com. Identifier: ISRCTN number 75451837. ? 2013 American Heart Association, Inc.
机译:背景:我们的目的是确定新诊断为2型糖尿病的人群中无声心肌梗塞(SMI)的患病率及其与未来心肌梗塞(MI)和全因死亡率的关系。方法和结果-:我们在30年的英国前瞻性糖尿病研究(UKPDS)中检查了5102例患者的数据,并使用Cox比例风险回归分析了SMI状态。在1967年具有完整基线数据的患者中,有326名(16.6%)在入组时具有SMI的ECG证据(明尼苏达州代码1.1或1.2)。与没有SMI的人相比,患有SMI的人更可能是年龄较大,女性,久坐和不吸烟的人。尽管加强了降压治疗,他们的平均血压还是更高。他们更有可能接受阿司匹林和降脂治疗;并且他们的微血管病患病率更高。在包括UKPDS风险引擎变量的多变量模型中,有和没有SMI的人的完全调整后的危险比对于致命MI分别为1.58(95%置信区间,1.22-2.05)和对所有MI的1.31(95%置信区间,1.10-1.56)。导致死亡。首发致命或非致命性心肌梗死和首发非致命性MI的危险比不显着。当将SMI添加到这些模型中时,净重分类指数没有改善,综合判别指数显示SMI可以稍微改善致命性MI和全因死亡率的预测。结论-:UKPDS新诊断的2型糖尿病患者中,每6例中就有1例具有SMI证据,这与致命性MI风险和全因死亡率增加独立相关。但是,SMI的识别并不会实质性地增加当前UKPDS风险引擎的预测变量。临床试验注册-:URL:http://www.control-trials.com。标识符:ISRCTN号75451837。 2013美国心脏协会有限公司

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号